Steven Lo Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Steven Lo.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Steven Lo. Steven Lo is SVP Oncology in CORCEPT THERAPEUTICS INC ($CORT) and VP Commercial Operations in CORCEPT THERAPEUTICS INC ($CORT) and Chief Commercial Officer in PUMA BIOTECHNOLOGY, INC. ($PBYI) and Chief Executive Officer in Zosano Pharma Corp ($ZSAN).
Latest Insider Trading Transactions of Steven Lo
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CORT, PBYI, ZSAN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 01 2021 | ZSAN | Zosano Pharma Corp | Lo Steven | Chief Executive Off ... | Option Exercise | A | 1.20 | 465,000 | 558,000 | 465,000 | |
| Apr 01 2021 | ZSAN | Zosano Pharma Corp | Lo Steven | Chief Executive Off ... | Grant | A | 0.00 | 232,500 | 0 | 378,750 | 146.3 K to 378.8 K (+158.97 %) |
| Apr 01 2021 | ZSAN | Zosano Pharma Corp | Lo Steven | Chief Executive Off ... | Option Exercise | A | 1.20 | 465,000 | 558,000 | 465,000 | |
| Apr 01 2021 | ZSAN | Zosano Pharma Corp | Lo Steven | Chief Executive Off ... | Grant | A | 0.00 | 232,500 | 0 | 378,750 | 146.3 K to 378.8 K (+158.97 %) |
| Mar 19 2021 | ZSAN | Zosano Pharma Corp | Lo Steven | Chief Executive Off ... | Option Exercise | A | 1.37 | 450,000 | 616,500 | 450,000 | |
| Jun 29 2020 | ZSAN | Zosano Pharma Corp | Lo Steven | Chief Executive Off ... | Grant | A | 0.00 | 146,250 | 0 | 146,250 | 0 to 146.3 K |
| Jun 05 2020 | ZSAN | Zosano Pharma Corp | Lo Steven | Chief Executive Off ... | Option Exercise | A | 1.01 | 292,500 | 295,425 | 292,500 | |
| Oct 23 2019 | ZSAN | Zosano Pharma Corp | Lo Steven | Chief Executive Off ... | Option Exercise | A | 1.94 | 450,000 | 873,000 | 450,000 | |
| Jul 24 2019 | PBYI | PUMA BIOTECHNOLOGY ... | Lo Steven | Chief Commercial Of ... | Sell | S | 10.04 | 1,852 | 18,600 | 19,557 | 21.4 K to 19.6 K (-8.65 %) |
| Feb 08 2019 | PBYI | PUMA BIOTECHNOLOGY ... | Lo Steven | Chief Commercial Of ... | Option Exercise | A | 27.76 | 36,300 | 1,007,688 | 36,300 | |
| Jan 24 2019 | PBYI | PUMA BIOTECHNOLOGY ... | Lo Steven | Chief Commercial Of ... | Sell | S | 24.91 | 2,114 | 52,664 | 21,409 | 23.5 K to 21.4 K (-8.99 %) |
| Jul 24 2018 | PBYI | PUMA BIOTECHNOLOGY ... | Lo Steven | Chief Commercial Of ... | Sell | S | 51.85 | 1,839 | 95,360 | 23,523 | 25.4 K to 23.5 K (-7.25 %) |
| Feb 13 2018 | PBYI | PUMA BIOTECHNOLOGY ... | Lo Steven | Chief Commercial Of ... | Option Exercise | A | 60.85 | 33,000 | 2,008,050 | 33,000 | |
| Jan 24 2018 | PBYI | PUMA BIOTECHNOLOGY ... | Lo Steven | Chief Commercial Of ... | Sell | S | 92.85 | 1,858 | 172,515 | 25,362 | 27.2 K to 25.4 K (-6.83 %) |
| Jul 24 2017 | PBYI | PUMA BIOTECHNOLOGY ... | Lo Steven | Chief Commercial Of ... | Sell | S | 94.90 | 1,990 | 188,853 | 27,220 | 29.2 K to 27.2 K (-6.81 %) |
| Feb 21 2017 | PBYI | PUMA BIOTECHNOLOGY ... | Lo Steven | Chief Commercial Of ... | Option Exercise | A | 37.35 | 31,500 | 1,176,525 | 31,500 | |
| Jan 24 2017 | PBYI | PUMA BIOTECHNOLOGY ... | Lo Steven | Chief Commercial Of ... | Sell | S | 33.24 | 2,290 | 76,108 | 29,210 | 31.5 K to 29.2 K (-7.27 %) |
| Oct 14 2016 | PBYI | PUMA BIOTECHNOLOGY ... | Lo Steven | Chief Commercial Of ... | Grant | A | 0.00 | 31,500 | 0 | 31,500 | 0 to 31.5 K |
| May 27 2016 | PBYI | PUMA BIOTECHNOLOGY ... | Lo Steven | Chief Commercial Of ... | Option Exercise | A | 35.61 | 30,000 | 1,068,300 | 30,000 | |
| Nov 16 2015 | CORT | CORCEPT THERAPEUTI ... | Lo Steven | SVP Oncology | Option Exercise | M | 1.92 | 87,500 | 168,000 | 0 | |
| Nov 16 2015 | CORT | CORCEPT THERAPEUTI ... | Lo Steven | SVP Oncology | Option Exercise | M | 2.08 | 64,583 | 134,010 | 0 | |
| Nov 16 2015 | CORT | CORCEPT THERAPEUTI ... | Lo Steven | SVP Oncology | Option Exercise | M | 2.70 | 33,333 | 89,999 | 0 | |
| Nov 16 2015 | CORT | CORCEPT THERAPEUTI ... | Lo Steven | SVP Oncology | Option Exercise | M | 3.51 | 286,040 | 1,004,000 | 0 | |
| Nov 16 2015 | CORT | CORCEPT THERAPEUTI ... | Lo Steven | SVP Oncology | Option Exercise | M | 3.51 | 113,960 | 400,000 | 0 | |
| Nov 16 2015 | CORT | CORCEPT THERAPEUTI ... | Lo Steven | SVP Oncology | Buy | M | 1.92 | 87,500 | 168,000 | 585,416 | 497.9 K to 585.4 K (+17.57 %) |
| Nov 16 2015 | CORT | CORCEPT THERAPEUTI ... | Lo Steven | SVP Oncology | Buy | M | 2.08 | 64,583 | 134,010 | 497,916 | 433.3 K to 497.9 K (+14.90 %) |
| Nov 16 2015 | CORT | CORCEPT THERAPEUTI ... | Lo Steven | SVP Oncology | Buy | M | 2.70 | 33,333 | 89,999 | 433,333 | 400 K to 433.3 K (+8.33 %) |
| Nov 16 2015 | CORT | CORCEPT THERAPEUTI ... | Lo Steven | SVP Oncology | Buy | M | 3.51 | 286,040 | 1,004,000 | 400,000 | 114 K to 400 K (+251.00 %) |
| Nov 16 2015 | CORT | CORCEPT THERAPEUTI ... | Lo Steven | SVP Oncology | Buy | M | 3.51 | 113,960 | 400,000 | 113,960 | 0 to 114 K |
| Nov 03 2015 | CORT | CORCEPT THERAPEUTI ... | Lo Steven | VP Commercial Opera ... | Option Exercise | M | 3.29 | 12,500 | 41,125 | 0 | |
| Nov 03 2015 | CORT | CORCEPT THERAPEUTI ... | Lo Steven | VP Commercial Opera ... | Buy | M | 3.29 | 12,500 | 41,125 | 12,500 | 0 to 12.5 K |
| Nov 03 2015 | CORT | CORCEPT THERAPEUTI ... | Lo Steven | VP Commercial Opera ... | Sell | S | 4.00 | 12,500 | 50,000 | 0 | 12.5 K to 0 (-100.00 %) |
| Oct 15 2015 | CORT | CORCEPT THERAPEUTI ... | Lo Steven | VP Commercial Opera ... | Sell | S | 3.82 | 53,033 | 202,586 | 0 | 53 K to 0 (-100.00 %) |
| Oct 09 2015 | CORT | CORCEPT THERAPEUTI ... | Lo Steven | VP Commercial Opera ... | Sell | S | 4.00 | 5,300 | 21,200 | 53,033 | 58.3 K to 53 K (-9.09 %) |
| Oct 07 2015 | CORT | CORCEPT THERAPEUTI ... | Lo Steven | VP Commercial Opera ... | Sell | S | 3.76 | 50,000 | 188,000 | 58,333 | 108.3 K to 58.3 K (-46.15 %) |
| Sep 30 2015 | CORT | CORCEPT THERAPEUTI ... | Lo Steven | VP Commercial Opera ... | Option Exercise | M | 2.70 | 108,333 | 292,499 | 33,333 | |
| Sep 30 2015 | CORT | CORCEPT THERAPEUTI ... | Lo Steven | VP Commercial Opera ... | Buy | M | 2.70 | 108,333 | 292,499 | 108,333 | 0 to 108.3 K |
| Sep 10 2015 | PBYI | PUMA BIOTECHNOLOGY ... | Lo Steven | Chief Commercial Of ... | Option Exercise | A | 95.22 | 150,000 | 14,283,000 | 150,000 | |
| Feb 23 2015 | CORT | CORCEPT THERAPEUTI ... | Lo Steven | VP Commercial Opera ... | Option Exercise | A | 3.29 | 100,000 | 329,000 | 100,000 | |
| Nov 21 2013 | CORT | CORCEPT THERAPEUTI ... | Lo Steven | VP Commercial Opera ... | Option Exercise | A | 1.92 | 200,000 | 384,000 | 200,000 | |
| Feb 01 2013 | CORT | CORCEPT THERAPEUTI ... | Lo Steven | VP Commercial Opera ... | Option Exercise | A | 2.08 | 100,000 | 207,500 | 100,000 | |
| Oct 12 2012 | CORT | CORCEPT THERAPEUTI ... | Lo Steven | VP Commercial Opera ... | Option Exercise | A | 2.70 | 200,000 | 540,000 | 200,000 | |
| Sep 28 2010 | CORT | CORCEPT THERAPEUTI ... | Lo Steven | VP Commercial Opera ... | Option Exercise | A | 3.51 | 400,000 | 1,404,000 | 400,000 |
Page: 1